Financial
    Budget

    GLP-1 Monthly Budget Guide: The True Cost of Weight Loss Treatment

    The sticker price of GLP-1 medication is not the whole story. When you factor in food savings, health cost reductions, and tax benefits, the true monthly cost may surprise you.

    Last updated: March 19, 202611 min read

    The question "Can I afford GLP-1 medication?" is the wrong question. The right question is "What is the net cost after accounting for all the financial changes that come with treatment?" For many patients taking semaglutide or tirzepatide, the medication nearly pays for itself through reduced food spending alone.

    Disclaimer

    Financial figures are estimates based on averages. Your actual costs and savings will vary based on individual circumstances.

    Direct Monthly Costs

    Monthly Cost Breakdown

    ExpenseSemaglutideTirzepatide
    Medication (Trimi)$125$125
    Provider consultationIncludedIncluded
    Injection supplies$5-$10$5-$10
    Protein supplement (optional)$20-$40$20-$40
    Lab work (amortized)$5-$15$5-$15
    Total Direct Cost$129-$164$155-$190

    Monthly Savings on GLP-1 Treatment

    Typical Monthly Savings

    Savings SourceMonthly Savings
    Reduced grocery spending$75-$200
    Fewer restaurant meals$50-$150
    Reduced snack/convenience food$30-$75
    No alcohol (many patients stop)$0-$100
    HSA/FSA tax savings$25-$50
    Reduced other medication costs$0-$100
    Total Savings$180-$675

    Calculating Your Net Monthly Cost

    For many Trimi patients, the net monthly cost of GLP-1 treatment is effectively zero or even negative. Take a conservative estimate: $140 in direct costs minus $180 in food and tax savings equals negative $40. You are actually saving money while getting medical treatment that improves your health and quality of life.

    Track your food spending for a month before starting medication, then compare it to your spending two to three months into treatment. Most patients are genuinely surprised by how much less they spend when appetite is properly regulated.

    Budget-Friendly Approaches

    Tight Budget ($100-$130/mo)

    Choose compounded semaglutide at $99/mo through Trimi. Skip optional supplements and focus on getting protein from affordable whole foods (eggs, chicken thighs, Greek yogurt, canned tuna). Use a free app for food tracking instead of paid services. Do bodyweight exercises at home instead of a gym membership.

    Moderate Budget ($150-$200/mo)

    Choose semaglutide or tirzepatide based on your clinical needs. Add a quality protein powder ($30/mo) for convenient post-workout nutrition. Consider a basic gym membership or online fitness subscription. Pay through your HSA or FSA for pre-tax savings.

    Flexible Budget ($200+/mo)

    Choose tirzepatide for maximum efficacy. Add protein supplements, a gym membership, and periodic lab monitoring. Consider adding therapy for psychological support. Invest in meal prep services or quality meal delivery to optimize nutrition.

    Smart Payment Strategies

    Use HSA or FSA funds for pre-tax payment. Set up automatic billing to avoid missed doses. Track all expenses for potential tax deductions. Redirect your food savings into a dedicated health account. And explore whether your employer offers wellness stipends that could offset costs.

    The Bottom Line

    GLP-1 treatment from Trimi costs less than most people spend on daily coffee. When you factor in the food savings, tax benefits, and long-term health cost reductions, the net cost is often zero or negative. Do not let sticker shock prevent you from exploring a treatment that could transform your health and potentially save you money.

    Affordable Treatment That Pays for Itself

    Semaglutide $99/mo. Tirzepatide $125/mo. No hidden fees.

    View Pricing

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 7, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Read our guide on Can Glp 1 Reduce Cancer Risk.

    Read our guide on Sarcopenia Risk Glp 1.

    Read our guide on Glp 1 Success Post Pregnancy.

    Read our guide on Retatrutide Compounding Quality.